Neurocrine CCO Doubles Down: Eric Bénévich Exercises 12,830 Options, Buys Shares Amid Quiet Stock Move—Insider Confidence Signals Possible Post‑Earnings Rally
Neurocrine insider Bénévich’s 12,830‑share option exercise signals strong confidence in its pipeline and may boost investor sentiment ahead of earnings.
3 minutes to read
